Singular Genomics Systems Inc expected to post a loss of 34 cents a share - Earnings Preview

Singular Genomics Systems

29/02/2024 21:04

* Singular Genomics Systems Inc  OMIC.OQ   OMIC.O  is
expected
to show a fall in quarterly revenue when it reports  results on
March 2 (estimated) for the period ending December 31 2023
    * The San Diego California-based  company is expected to
report a
22.5% decrease in revenue to $592.67 thousand from $765 thousand
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Singular Genomics
Systems Inc
is for a loss of 34 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Singular
Genomics
Systems Inc is $0.63​, above​ its last closing price of $0.59.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.38       -0.38      -0.31     Beat    18.4
 Jun. 30 2023  -0.39       -0.37      -0.35     Beat    5.4
 Mar. 31 2023  -0.35       -0.35      -0.33     Beat    6.8​
 Dec. 31 2022  -0.41       -0.43      -0.29     Beat    31.9
 ​​Sep.        -0.41       -0.41      -0.33     Beat    20.3
 30 2022                                                
 Jun. 30 2022  -0.39       -0.38      -0.34     Beat    11.5​
 Mar. 31 2022  -0.33       -0.33      -0.31     Beat    7
 Dec. 31 2021  -0.31       -0.31      -0.27     Beat    12.3
 This summary was machine generated February 29 at 21:04 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)